| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Liabilities Shareholders' Equity | 109.84 | 79.96 | 78.90 | 81.62 |
| Accumulated Depreciation Total | -2.01 | -1.66 | - | - |
| Other Liabilities Total | 0.26 | 0.20 | 0.19 | 0.19 |
| Accrued Expenses | 0.27 | 0.31 | - | - |
| Long Term Debt | 4.20 | 3.60 | 5.23 | 3.11 |
| Common Stock Total | 26.09 | 10.72 | 10.55 | 10.55 |
| Other Equity Total | 0.19 | 0.18 | - | - |
| Other Current Assets Total | 0.58 | 0.55 | 3.59 | 4.27 |
| Prepaid Expenses | 0.06 | 0.04 | - | - |
| Total Assets | 109.84 | 79.96 | 78.90 | 81.62 |
| Current Portof LT Debt/ Capital Leases | 3.40 | 2.04 | 1.29 | 0.97 |
| Additional Paid- In Capital | 22.91 | 17.03 | - | - |
| Cash | 1.71 | 1.46 | - | - |
| Total Equity | 64.92 | 42.84 | 40.53 | 26.35 |
| Long Term Investments | 1.75 | 1.75 | 2.71 | 2.65 |
| Retained Earnings( Accumulated Deficit) | 15.73 | 14.91 | 29.99 | 15.81 |
| Total Common Shares Outstanding | 13.05 | 10.72 | 10.55 | 10.55 |
| Property/ Plant/ Equipment Total- Gross | 3.17 | 3.11 | - | - |
| Tangible Book Valueper Share Common Eq | 4.91 | 3.92 | 3.76 | 2.43 |
| Total Liabilities | 44.93 | 37.12 | 38.37 | 55.27 |
| Total Debt | 12.32 | 13.49 | 14.74 | 20.81 |
| Short Term Investments | 28.28 | 12.01 | 11.44 | 11.86 |
| Cashand Short Term Investments | 29.99 | 13.47 | 12.42 | 13.02 |
| Total Receivables Net | 47.66 | 50.11 | 53.61 | 58.51 |
| Notes Payable/ Short Term Debt | 4.30 | 7.62 | 7.34 | 16.69 |
| Accounts Receivable- Trade Net | 46.72 | 49.43 | 53.61 | 58.51 |
| Property/ Plant/ Equipment Total- Net | 1.16 | 1.46 | 1.80 | 0.90 |
| Total Current Liabilities | 40.05 | 33.08 | 32.07 | 51.94 |
| Total Inventory | 26.20 | 10.35 | 3.05 | 0.63 |
| Accounts Payable | 27.14 | 19.39 | 18.00 | 28.38 |
| Other Currentliabilities Total | 4.94 | 3.72 | 5.44 | 5.89 |
| Total Long Term Debt | 4.62 | 3.83 | 6.11 | 3.14 |
| Intangibles Net | 0.92 | 0.80 | 0.86 | 0.77 |
| Other Long Term Assets Total | 0.80 | 0.71 | 0.86 | 0.88 |
| Note Receivable- Long Term | 0.73 | 0.72 | - | - |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 104.48 | 74.52 | 72.67 | 76.43 |
| Capital Lease Obligations | 0.42 | 0.24 | 0.88 | 0.04 |
| Cash Equivalents | - | - | 0.98 | 1.16 |
Vaishali Pharma Dividend Vaishali Pharma Bonus Vaishali Pharma News Vaishali Pharma AGM Vaishali Pharma Rights Vaishali Pharma Splits Vaishali Pharma Board Meetings Vaishali Pharma Key Metrics Vaishali Pharma Shareholdings Vaishali Pharma Profit Loss Vaishali Pharma Cashflow Vaishali Pharma Q1 Results Vaishali Pharma Q2 Results Vaishali Pharma Q3 Results Vaishali Pharma Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.